RSPO4 and thyroid gland carcinoma: The CRISPR-RSPO4 and CRISPR-BRAF knockout carried out discrete changes in cellular morphology, however the knockout condition significantly impacted on the phenotype of metastatic and non-metastatic thyroid cancer cell lines by significantly decrease the proliferation, invasion, and migration status (Figure 6E–H).